These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16129645)

  • 1. [Coasting and ovarian stimulation protocols in high-responder patients undergoing assisted conception].
    Merviel P; Claeys C; Héraud MH; Lourdel E; Lanta S; Barbier F; Nasreddine A
    Gynecol Obstet Fertil; 2005 Sep; 33(9):703-12. PubMed ID: 16129645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
    Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
    Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does coasting, a procedure to avoid ovarian hyperstimulation syndrome, affect assisted reproduction cycle outcome?
    Yilmaz N; Uygur D; Ozgu E; Batioglu S
    Fertil Steril; 2010 Jun; 94(1):189-93. PubMed ID: 19376515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
    Zarek SM; Muasher SJ
    Fertil Steril; 2011 Jun; 95(8):2449-55. PubMed ID: 21550037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian hyperstimulation syndrome prevention strategies: oral contraceptive pills-dual gonadotropin-releasing hormone agonist suppression with step-down gonadotropin protocols.
    Damario MA
    Semin Reprod Med; 2010 Nov; 28(6):468-74. PubMed ID: 21082505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
    Ho Yuen B; Nguyen TA; Cheung AP; Leung PC
    Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of coasting in patients undergoing controlled ovarian stimulation with the gonadotropin-releasing hormone antagonist cetrorelix.
    Bahceci M; Ulug U; Tosun S; Erden HF; Bayazit N
    Fertil Steril; 2006 May; 85(5):1523-5. PubMed ID: 16566935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
    Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
    Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coasting: a response to excessive ovarian stimulation].
    Dechaud H; Anahory T; Aligier N; Arnal F; Humeau C; Hédon B
    Gynecol Obstet Fertil; 2000 Feb; 28(2):115-9. PubMed ID: 10758585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome.
    Mathur R; Kailasam C; Jenkins J
    Hum Fertil (Camb); 2007 Jun; 10(2):75-85. PubMed ID: 17564886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyperstimulation syndrome prevention strategies: use of gonadotropin-releasing hormone antagonists.
    Griesinger G
    Semin Reprod Med; 2010 Nov; 28(6):493-9. PubMed ID: 21082508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception.
    Ulug U; Ben-Shlomo I; Bahceci M
    Fertil Steril; 2004 Aug; 82(2):338-42. PubMed ID: 15302281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withholding gonadotropins until human chorionic gonadotropin administration.
    Abdallah R; Kligman I; Davis O; Rosenwaks Z
    Semin Reprod Med; 2010 Nov; 28(6):486-92. PubMed ID: 21082507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is mild stimulation?].
    Merviel P; Lourdel E; Cabry R; Boulard V; Scheffler F; Dupond S; Lombart M; Marc C
    Gynecol Obstet Fertil; 2012 Sep; 40(9):467-71. PubMed ID: 22920234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pituitary down-regulation and ovulation stimulation with gradually increased gonadotropin in controlled ovarian hyperstimulation].
    Zhu L; Song YL; Cui YG; Xing FQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):361-3. PubMed ID: 17425993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor responder protocols for in-vitro fertilization: options and results.
    Loutradis D; Vomvolaki E; Drakakis P
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):374-8. PubMed ID: 18660689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG
    Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coasting. A viable option for patients at risk of ovarian hyperstimulation syndrome.
    Gafar AH; Abotalib ZM
    Saudi Med J; 2002 Nov; 23(11):1398-401. PubMed ID: 12506304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.